Correspondingly, Myeloperoxidase (MPO) protein is another protein that demonstrated reduced expression in CLL cells and heavily affected patient survival from the initial stages of disease development (p = 2.686 × 10−13). This evidence concerns the gene MPO and B-cell chronic lymphocytic leukemia.